All Stories

  1. Design, 3D QSAR modeling and docking of TGF-β type I inhibitors to target cancer
  2. Anticancer work with novel thiazolidinone
  3. Design, synthesis and biological evaluation of 2-(4-phenylthiazol-2-yl) isoindoline-1,3-dione derivatives as anti-prostate cancer agents
  4. Synthesis, spectroscopic investigations (FT-IR, NMR, UV–Vis, and TD-DFT), and molecular docking of (E)-1-(benzo[d][1, 3]dioxol-6-yl)-3-(6-methoxynaphthalen-2-yl)prop-2-en-1-one
  5. 4-Chloro-N-(isoquinolin-3-yl)butanamide
  6. Synthesis of novel 1,3-thiazin-4-ones by acetylene diester cyclization and their anticancer activities
  7. 2-Chloro-N-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]acetamide
  8. Molecular structure, NMR, UV–Visible, vibrational spectroscopic and HOMO, LUMO analysis of (E)-1-(2, 6-bis (4-methoxyphenyl)-3, 3-dimethylpiperidine-4-ylidene)-2-(3-(3, 5-dimethyl-1H-pyrazol-1-yl) pyrazin-2-yl) hydrazine by DFT method
  9. FT-IR, FT-Raman, UV, NMR spectra and molecular structure investigation of (E)-2-(3-chloropyrazin-2-yl)-1-(3-ethyl-2, 6-diphenyl piperidin-4-ylidene) hydrazine: A combined experimental and theoretical study
  10. Comparison of Molecular Docking and Molecular Dynamics Simulations of 1,3-Thiazin-4-One with MDM2 Protein
  11. Synthesis, structure prediction, pharmacokinetic properties, molecular docking and antitumor activities of some novel thiazinone derivatives
  12. 3-[(4-Oxo-4H-thiochromen-3-yl)methyl]-4H-thiochromen-4-one